Aya Fujinami

1.1k total citations
35 papers, 848 citations indexed

About

Aya Fujinami is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Aya Fujinami has authored 35 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Aya Fujinami's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Nerve injury and regeneration (5 papers). Aya Fujinami is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Nerve injury and regeneration (5 papers). Aya Fujinami collaborates with scholars based in Japan, United States and Czechia. Aya Fujinami's co-authors include Mitsuhiro Ohta, Kiyoe Ohta, Hiroshi Obayashi, Goji Hasegawa, Michiaki Fukui, Sadako Kuno, Hidehito Matsui, Naoto Nakamura, Saeko Imai and Toshikazu Yoshikawa and has published in prestigious journals such as PLoS ONE, Neurology and Clinical Chemistry.

In The Last Decade

Aya Fujinami

34 papers receiving 817 citations

Peers

Aya Fujinami
Kallirhoe Kalinderi Greece
M Ferrari Brazil
Mehmet Erşahin Türkiye
Ángel Luis Garcı́a-Villalón Spain
Jennifer O’Connell United States
Jirapas Sripetchwandee Thailand
Hiroki Yokoo Japan
Maciej Suski Poland
D. S. Goldstein United States
Hung‐Ming Wu Taiwan
Kallirhoe Kalinderi Greece
Aya Fujinami
Citations per year, relative to Aya Fujinami Aya Fujinami (= 1×) peers Kallirhoe Kalinderi

Countries citing papers authored by Aya Fujinami

Since Specialization
Citations

This map shows the geographic impact of Aya Fujinami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aya Fujinami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aya Fujinami more than expected).

Fields of papers citing papers by Aya Fujinami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aya Fujinami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aya Fujinami. The network helps show where Aya Fujinami may publish in the future.

Co-authorship network of co-authors of Aya Fujinami

This figure shows the co-authorship network connecting the top 25 collaborators of Aya Fujinami. A scholar is included among the top collaborators of Aya Fujinami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aya Fujinami. Aya Fujinami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tagawa, Noriko, et al.. (2022). Relationship between adiponectin multimer levels and subtypes of cerebral infarction. PLoS ONE. 17(1). e0262542–e0262542. 2 indexed citations
3.
Imoto, Susumu, Soo Ryang Kim, Etsuko Iio, et al.. (2017). Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C. Digestive Diseases. 35(6). 531–540.
4.
Ohta, Mitsuhiro, Aya Fujinami, Norihiro Kobayashi, et al.. (2015). Two chalcones, 4-hydroxyderricin and xanthoangelol, stimulate GLUT4-dependent glucose uptake through the LKB1/AMP-activated protein kinase signaling pathway in 3T3-L1 adipocytes. Nutrition Research. 35(7). 618–625. 19 indexed citations
5.
Kim, Soo Ryang, Ahmed El‐Shamy, Susumu Imoto, et al.. (2013). Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load. Digestive Diseases. 31(5-6). 426–433. 2 indexed citations
6.
Kim, Soo Ryang, Ahmed El‐Shamy, Susumu Imoto, et al.. (2013). Outcome of Double-Filtration Plasmapheresis plus Interferon Treatment in Nonresponders to Pegylated Interferon plus Ribavirin Combination Therapy. Digestive Diseases. 31(5-6). 434–439. 3 indexed citations
7.
Fukui, Michiaki, Muhei Tanaka, Mai Asano, et al.. (2012). Serum allograft inflammatory factor-1 is a novel marker for diabetic nephropathy. Diabetes Research and Clinical Practice. 97(1). 146–150. 18 indexed citations
8.
Fukui, Michiaki, Muhei Tanaka, Hitoshi Toda, et al.. (2012). The serum concentration of allograft inflammatory factor–1 is correlated with metabolic parameters in healthy subjects. Metabolism. 61(7). 1021–1025. 19 indexed citations
9.
10.
Ohta, Kiyoe, Sadako Kuno, S Inoué, et al.. (2010). The effect of dopamine agonists: The expression of GDNF, NGF, and BDNF in cultured mouse astrocytes. Journal of the Neurological Sciences. 291(1-2). 12–16. 42 indexed citations
11.
Hasegawa, Goji, Michiaki Fukui, Hiroko Hosoda, et al.. (2009). Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats. European Journal of Pharmacology. 605(1-3). 164–169. 29 indexed citations
12.
Hasegawa, Goji, Shizuo Kajiyama, Toru Tanaka, et al.. (2008). The α-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes. Clinica Chimica Acta. 390(1-2). 110–114. 19 indexed citations
13.
Ohta, K, Kazuhiro Shigemoto, Aya Fujinami, et al.. (2007). Clinical and experimental features of MuSK antibody positive MG in Japan. European Journal of Neurology. 14(9). 1029–1034. 67 indexed citations
14.
Park, Hyohun, Goji Hasegawa, Hiroshi Obayashi, et al.. (2006). Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension. Clinica Chimica Acta. 374(1-2). 129–134. 19 indexed citations
15.
Fujinami, Aya, Kiyoe Ohta, Hidehito Matsui, et al.. (2006). Resistin Concentrations in Murine Adipose Tissue and Serum Measured by a New Enzyme Immunoassay. Obesity. 14(2). 199–205. 5 indexed citations
16.
17.
18.
Ohta, Kiyoe, Sadako Kuno, Ikuko Mizuta, et al.. (2003). Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sciences. 73(5). 617–626. 53 indexed citations
19.
Tagawa, Noriko, Aya Fujinami, Toshiko Kiguchi, et al.. (2000). Heterologous enzyme immunoassay for serum androstenediol. Clinica Chimica Acta. 296(1-2). 193–201. 7 indexed citations
20.
Tagawa, Noriko, et al.. (1999). Simultaneous determination of estriol and estriol 3-sulfate in serum by column-switching semi-micro high-performance liquid chromatography with ultraviolet and electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 723(1-2). 39–45. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kallirhoe Kalinderi Breakdown of academic impact, for papers by M Ferrari Breakdown of academic impact, for papers by Mehmet Erşahin Breakdown of academic impact, for papers by Ángel Luis Garcı́a-Villalón Breakdown of academic impact, for papers by Jennifer O’Connell Breakdown of academic impact, for papers by Jirapas Sripetchwandee Breakdown of academic impact, for papers by Hiroki Yokoo Breakdown of academic impact, for papers by Maciej Suski Breakdown of academic impact, for papers by D. S. Goldstein Breakdown of academic impact, for papers by Hung‐Ming Wu
Rankless by CCL
2026